Ourliac-Garnier, I. | IICIMED

Ourliac-Garnier, I.

Maître de Conférences – HDR

Publications

P302

Inorg. Chem., 2025, 64, 16192-16203. 

Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold.

Zhong, S. | Kalamatianou, A. | Scalese, G. | O'Beirne, C. | Redrado, M. | Blacque, O. | Picot, C. | Tomasoni, C. | Logé, C. | Albassier, M. | Ourliac-Garnier, I. | Pagniez, F. | Le Pape, P. | Pérez-Díaz, L. | Gambino, D. | Comini, M. A. | Cariou, K. | Gasser, G.

https://doi.org/10.1021/acs.inorgchem.5c02730

P301

J. Med. Mycol. 2025, 101583.

A One Health Perspective on Diutina catenulata: Phenotypic Traits, Stress Sensitivity, and Virulence Across Diverse Isolates.

Prudencio de Albuquerque, I. K. | Morio, F. | Albassier, M. | Baron, L. | Duchesne, L. | Le Pape, P. | Ourliac-Garnier, I.

https://doi.org/10.1016/j.mycmed.2025.101583

P278

Antimicrob. Agents Chemother. 2024, e0002224.

Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis.

Hartuis, S. | Ourliac-Garnier, I. | Robert, E. | Albassier, M. | Duchesne, L. | Beaufils, C. | Kuhn, J. | Le Pape, P. | Morio, F.

https://doi.org/10.1128/aac.00022-24

P273

In: Barreiro, C., Barredo, JL. (eds) Microbial Steroids. Methods in Molecular Biology, vol 2704. Humana, New York, NY. 2023

Fungal Sterol Analyses by Gas Chromatography–Mass Spectrometry Using Different Derivatives.

Mossion, A. | Ourliac-Garnier, I. | Wielgosz-Collin, G.

https://doi.org/10.1007/978-1-0716-3385-4_8

P268

Future Microbiol. 2023, 18, 1225-1233.

Antifungal efficacy of imidazo[1,2-a]pyrazine based thiosemicarbazones and thiazolidinediones against Sporothrix species.

Gonçalves de Lima Neto, R. | Saraiva de Araújo Neta, M. | Tiburcio Valeriano, C. A. | Pereira Neves, R. | Lacerda, A. M. | Ferraz, C. E. | Inácio, C. P. | Le Pape, P. | Ourliac-Garnier, I. | de Faria, A. R. | da Silva, T. G. | Alves Pereira, V. R. | Marchand, P.

https://doi.org/10.2217/fmb-2023-0044

P246

Microorganisms. 2022, 10, 104. 

Impact of TR34/L98H, TR46/Y121F/T289A and TR53 alterations in azole‐resistant Aspergillus fumigatus on sterol composition and modifications after In Vitro exposure to itraconazole and voriconazole.

Lavergne, R.-A. | Albassier, M. | Hardouin, J.‐B. | Alvarez‐Moreno, C. | Pagniez, F. | Morio, F. | Le Pape, P. | Ourliac-Garnier, I.

https://doi.org/10.3390/microorganisms10010104

P240

Molecules 2021, 26, 6572.

Dibenzofuran derivatives inspired from cercosporamide as dual inhibitors of Pim and CLK1 kinases.

Dao, V. H. | Ourliac-Garnier, I. | Logé, C. | McCarthy, F. O. | Bach, S. | da Silva, T. G. | Denevault-Sabourin, C. | Thiéfaine, J. | Baratte, B. | Robert, T. | Gouilleux, F. | Brachet-Botineau, M. | Bazin, M.-A. | Marchand, P.

doi: 10.3390/molecules26216572

P231

Eur. J. Med. Chem. 2021, 210, 112956.

In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition.

Bazin, M.-A. | Cojean, S. | Pagniez, F. | Bernadat, G. | Cavé, C. | Ourliac-Garnier, I. | Nourrisson, M.-R. | Morgado, C. | Picot, C. | Leclercq, O. | Baratte, B. | Robert, T. | Späth, G.F. | Rachidi, N. | Bach, S. | Loiseau, P.M. | Le Pape, P. | Marchand, P.

doi: 10.1016/j.ejmech.2020.112956

P220

I 2020, 113366.

Determination of antifungal caspofungin in RPMI-1640 cell culture medium bycolumn-switching HPLC-FLD.

Uribe, B. | González, O. | Ourliac-Garnier, I. | Le Pape, P. | Ba, B. B. | Alonso, R.M. | Gaudin, K.

doi : 10.1016/j.jpba.2020.113366

P212

 Eur. J. Med. Chem. 2020, 189, 112082.

New Azole Antifungals with a Fused Triazinone Scaffold.

Montoir, D. | Guillon, R. | Gazzola, S. | Ourliac-Garnier, I. | Efouako Soklou, K. | A Tonnerre, A. | Picot, C. | Planchat, A. | Pagniez, F. | Le Pape, P. | Logé, C.

doi: 10.1016/j.ejmech.2020.112082

P208

J. Enzym. Inhib. Med. Chem. 2020, 35, 398-403.

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.

Pagniez, F. | Lebouvier, N. | Na, Y. M. | Ourliac-Garnier, I. | Picot, C. | Le Borgne, M. | Le Pape, P.

doi: 10.1080/14756366.2019.1705292

P205

Pharmaceuticals 2019, 12, 182;

A decade of antifungal leads from natural products: 2010-2019.

Aldholmi, M. | Marchand, P. | Ourliac-Garnier, I. | Le Pape, P. | Ganesan, A.

doi:10.3390/ph12040182.

P173

Bioorg. Med. Chem. Lett. 2018, 28, 2250-2255.

Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: synthesis and evaluation of fluconazole susceptibility restoration.

Dao, V.H. | Ourliac-Garnier, I. | Bazin, M.-A. | Jacquot, C. | Baratte, B. | Ruchaud, S. | Bach, S. | Grovel, O. | Le Pape, P. | Marchand, P.

doi: 10.1016/j.bmcl.2018.05.044

Autres publications scientifiques

PS36

Pharmaceuticals 2025, 18, 837.

New insights into the anticancer effects and toxicogenomic safety of two β-Lapachone derivatives.

Rivaldo de Lima, J. | Da Silva Góes, A. J. | De Oliveira Borba, E. F. | da Silva, M. A. | Caiana, R. R. A. | do Desterro Rodrigues, M. | De Lima Silva, M. S. | Chagas, C. A. | Baratte, B. | Robert, T. | Bach, S. | Ourliac-Garnier, I. | Marchand, P. | Gonçalves da Silva, T.

https://doi.org/10.3390/ph18060837

Brevets

Thèse